Felbamate monotherapy: Controlled trial
β
Rajesh Sachdeo; Lynn D. Kramer; Alberto Rosenberg; Dr. Satinder Sachdeo
π
Article
π
1992
π
John Wiley and Sons
π
English
β 658 KB
Felbamate (FBM) monotherapy was evaluated in 44 patients with uncontrolled partial onset seizures in a unique, single-center, randomized, double-blind, parallel-group trial. During the 56-day baseline peripd, patients were required to have at least 8 seizures and to be receiving only one standard an